Paper42608317
Oleanolic Acid-Enriched Olive Oil Attenuates Kidney Function Decline in Patients With Type 2 Diabetes: Results From the OLTRAD Randomised Controlled Trial.
García-González A and 14 others. Diabetes Obes Metab, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Oleanolic Acid-Enriched Olive Oil Attenuates Kidney Function Decline in Patients With Type 2 Diabetes: Results From the OLTRAD Randomised Controlled Trial. Papers, record 42608317. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42608317
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Oleanolic Acid-Enriched Olive Oil Attenuates Kidney Function Decline in Patients With Type 2 Diabetes: Results From the OLTRAD Randomised Controlled Trial.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Diabetic Nephropathies | Major topic |
| Kidney | Major topic |
| Oleanolic Acid | Major topic |
| Olive Oil | Major topic |
| Renal Insufficiency, Chronic | Major topic |
| Aged | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Albuminuria | |
| Glomerular Filtration Rate | |
| Glycation End Products, Advanced | |
| Oxidative Stress |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MCIN/AEI/10.13039/501100011033/ | Spanish Ministry of Science and Innovation/Spanish State Research Agency (Agencia Estatal de Investigación, AEI) | PubMed | ||
| DGP_PRED_2024_00736 | the Andalusian Regional Government/Regional Ministry of University, Research and Innovation and the European Social Fund Plus (ESF+) | PubMed | ||
| European Union through the Next Generation EU funds and the Recovery, Transformation and Resilience Plan, and by the Ministry of Universities | PubMed |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT06030544 | Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY) | Derived from the trial | Yes |
Source ClinicalTrials.gov
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 42131237 | Gut microbiota-liver-kidney axis in diabetic kidney disease: mechanistic insights into amino acid metabolism and nutritional intervention strategies targeting natural bioactive compounds. | Front Nutr | 2026 | https://conductscience.org/library/papers/42131237 | PubMed |
| 2 | 34277660 | Advanced-Glycation End-Products Induce Podocyte Injury and Contribute to Proteinuria. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/34277660 | PubMed |
| 3 | 35458168 | Molecular Mechanisms Underlying the Effects of Olive Oil Triterpenic Acids in Obesity and Related Diseases. | Nutrients | 2022 | https://conductscience.org/library/papers/35458168 | PubMed |
| 4 | 39587094 | Emerging mechanisms of lipid peroxidation in regulated cell death and its physiological implications. | Cell Death Dis | 2024 | https://conductscience.org/library/papers/39587094 | PubMed |
| 5 | 25515513 | Oleanolic acid and related triterpenoids from olives on vascular function: molecular mechanisms and therapeutic perspectives. | Curr Med Chem | 2015 | https://conductscience.org/library/papers/25515513 | PubMed |
| 6 | 35648704 | Uses of GFR and Albuminuria Level in Acute and Chronic Kidney Disease. | N Engl J Med | 2022 | https://conductscience.org/library/papers/35648704 | PubMed |
| 7 | 27771930 | CDDO and Its Role in Chronic Diseases. | Adv Exp Med Biol | 2016 | https://conductscience.org/library/papers/27771930 | PubMed |
| 8 | 1901236 | The role of the polyol pathway in diabetes mellitus. | Br J Hosp Med | 1991 | https://conductscience.org/library/papers/1901236 | PubMed |
| 9 | 34942356 | Methods to investigate advanced glycation end-product and their application in clinical practice. | Methods | 2022 | https://conductscience.org/library/papers/34942356 | PubMed |
| 10 | 31221677 | Progressive Decline in Estimated Glomerular Filtration Rate in Patients With Diabetes After Moderate Loss in Kidney Function-Even Without Albuminuria. | Diabetes Care | 2019 | https://conductscience.org/library/papers/31221677 | PubMed |
| 11 | 35030530 | Long-term consumption of a mediterranean diet or a low-fat diet on kidney function in coronary heart disease patients: The CORDIOPREV randomized controlled trial. | Clin Nutr | 2022 | https://conductscience.org/library/papers/35030530 | PubMed |
| 12 | 10564016 | Quantitative determination of hydroxy pentacyclic triterpene acids in vegetable oils. | J Agric Food Chem | 1999 | https://conductscience.org/library/papers/10564016 | PubMed |
| 13 | 12393931 | Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction. | Mol Med | 2002 | https://conductscience.org/library/papers/12393931 | PubMed |
| 14 | 25943913 | GC-FID determination and pharmacokinetic studies of oleanolic acid in human serum. | Biomed Chromatogr | 2015 | https://conductscience.org/library/papers/25943913 | PubMed |
| 15 | 12429856 | Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. | Proc Natl Acad Sci U S A | 2002 | https://conductscience.org/library/papers/12429856 | PubMed |
| 16 | 25589951 | Chronic kidney disease in the elderly: evaluation and management. | Clin Pract (Lond) | 2014 | https://conductscience.org/library/papers/25589951 | PubMed |
| 17 | 33932738 | Preventing the onset of diabetes-induced chronic kidney disease during prediabetes: The effects of oleanolic acid on selected markers of chronic kidney disease in a diet-induced prediabetic rat model. | Biomed Pharmacother | 2021 | https://conductscience.org/library/papers/33932738 | PubMed |
| 18 | 22908267 | Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22908267 | PubMed |
| 19 | 40427479 | Oleanolic Acid: A Promising Antioxidant-Sources, Mechanisms of Action, Therapeutic Potential, and Enhancement of Bioactivity. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40427479 | PubMed |
| 20 | 23704520 | Biochemical basis of the antidiabetic activity of oleanolic acid and related pentacyclic triterpenes. | Diabetes | 2013 | https://conductscience.org/library/papers/23704520 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42608317 | Oleanolic Acid-Enriched Olive Oil Attenuates Kidney Function Decline in Patients With Type 2 Diabetes: Results From the OLTRAD Randomised Controlled Trial. | Diabetes Obes Metab | 2026 | https://conductscience.org/library/papers/42608317 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42608317
GET https://conductscience.org/api/papers/v1/42608317/references?page=2